Oteseconazole | Interleukin Related interleukin-related.com

Product Name :
Oteseconazole

Search keywords :
Cytochrome P450

drugId :
null

Target Vo:
Cytochrome P450 51

Target Vo Short Name :
CYP51

Moa_Name:
Cytochrome P450 51 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2022

Origin Company_Name :
Viamet Pharmaceuticals

Active Company_Name :
Evenus Pharmaceutical Laboratories Inc

Active Indication_Name:
Candidiasis, Vulvovaginal

In Active Indication_Name:
Onychomycosis

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
BRAF (YP5013) Mouse mAb Autophagy
Osocimab Metabolic Enzyme/Protease
SNAI1 Antibody: SNAI1 Antibody is an unconjugated, approximately 29 kDa, rabbit-derived, anti-SNAI1 polyclonal antibody. SNAI1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, and predicted: mouse, rat background without labeling.

Author: Interleukin Related

Related Posts